223 related articles for article (PubMed ID: 33132073)
1. Predicting which patients may benefit from the hybrid intracavitary+interstitial needle (IC/IS) applicator for advanced cervical cancer: A dosimetric comparison and toxicity benefit analysis.
Gonzalez Y; Giap F; Klages P; Owrangi A; Jia X; Albuquerque K
Brachytherapy; 2021; 20(1):136-145. PubMed ID: 33132073
[TBL] [Abstract][Full Text] [Related]
2. Point A vs. HR-CTV D
Harmon G; Diak A; Shea SM; Yacoub JH; Small W; Harkenrider MM
Brachytherapy; 2016; 15(6):825-831. PubMed ID: 27693173
[TBL] [Abstract][Full Text] [Related]
3. Combined intracavitary and interstitial brachytherapy of cervical cancer using the novel hybrid applicator Venezia: Clinical feasibility and initial results.
Walter F; Maihöfer C; Schüttrumpf L; Well J; Burges A; Ertl-Wagner B; Mahner S; Belka C; Gallwas J; Corradini S
Brachytherapy; 2018; 17(5):775-781. PubMed ID: 29941345
[TBL] [Abstract][Full Text] [Related]
4. Outcomes and comparison of dosimetric parameters between intracavitary (Fletcher) and combined intracavitary/interstitial (Utrecht) brachytherapy in locally advanced cervical cancer.
Sarwar KA; Hussain S; Syed AS; Khan K; Maqsood T; Azeem T
Brachytherapy; 2024; 23(1):10-17. PubMed ID: 37813708
[TBL] [Abstract][Full Text] [Related]
5. Clinical use of the Utrecht applicator for combined intracavitary/interstitial brachytherapy treatment in locally advanced cervical cancer.
Nomden CN; de Leeuw AA; Moerland MA; Roesink JM; Tersteeg RJ; Jürgenliemk-Schulz IM
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1424-30. PubMed ID: 21669505
[TBL] [Abstract][Full Text] [Related]
6. Clinical feasibility of interstitial brachytherapy using a "hybrid" applicator combining uterine tandem and interstitial metal needles based on CT for locally advanced cervical cancer.
Liu ZS; Guo J; Lin X; Wang HY; Qiu L; Ren XJ; Li YF; Zhang BY; Wang TJ
Brachytherapy; 2016; 15(5):562-9. PubMed ID: 27474180
[TBL] [Abstract][Full Text] [Related]
7. A novel two-step optimization method for tandem and ovoid high-dose-rate brachytherapy treatment for locally advanced cervical cancer.
Sharma M; Fields EC; Todor DA
Brachytherapy; 2015; 14(5):613-8. PubMed ID: 26092424
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the Dosimetric Influence of Applicator Displacement on 2D and 3D Brachytherapy for Cervical Cancer Treatment.
Wu A; Tang D; Wu A; Liu Y; Qian L; Zhu L
Technol Cancer Res Treat; 2021; 20():15330338211041201. PubMed ID: 34569371
[TBL] [Abstract][Full Text] [Related]
9. Dosimetric considerations when utilizing Venezia, Capri, Rotte double tandem, and tandem and ring with interstitial needles for the treatment of gynecological cancers with high dose rate brachytherapy.
Schnell E; Thompson S; Ahmad S; Herman TS; De La Fuente Herman T
Med Dosim; 2020 Spring; 45(1):21-27. PubMed ID: 31101569
[TBL] [Abstract][Full Text] [Related]
10. New inverse planning technology for image-guided cervical cancer brachytherapy: description and evaluation within a clinical frame.
Trnková P; Pötter R; Baltas D; Karabis A; Fidarova E; Dimopoulos J; Georg D; Kirisits C
Radiother Oncol; 2009 Nov; 93(2):331-40. PubMed ID: 19846230
[TBL] [Abstract][Full Text] [Related]
11. Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients.
Ribeiro I; Janssen H; De Brabandere M; Nulens A; De Bal D; Vergote I; Van Limbergen E
Radiother Oncol; 2016 Sep; 120(3):447-454. PubMed ID: 27157510
[TBL] [Abstract][Full Text] [Related]
12. The addition of interstitial needles to intracavitary applicators in the treatment of locally advanced cervical cancer: Why is this important and how to implement in low- and middle-income countries?
Lombe D; Crook J; Bachand F; Moore J; Hamm J; Rose T; Anderson D; Batchelar D
Brachytherapy; 2020; 19(3):316-322. PubMed ID: 32229073
[TBL] [Abstract][Full Text] [Related]
13. Early outcomes and impact of a hybrid IC/IS applicator for a new MRI-based cervical brachytherapy program.
Harkenrider MM; Surucu M; Harmon G; Mysz ML; Shea SM; Yacoub J; Goldberg A; Liotta M; Winder A; Potkul R; Roeske JC; Small W
Brachytherapy; 2018; 17(1):187-193. PubMed ID: 29089277
[TBL] [Abstract][Full Text] [Related]
14. Proof of principle: Applicator-guided stereotactic IMRT boost in combination with 3D MRI-based brachytherapy in locally advanced cervical cancer.
Assenholt MS; Vestergaard A; Kallehauge JF; Mohamed S; Nielsen SK; Petersen JB; Fokdal L; Lindegaard JC; Tanderup K
Brachytherapy; 2014; 13(4):361-8. PubMed ID: 24656732
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of dose differences between intracavitary applicators for cervical brachytherapy using knowledge-based models.
Kallis K; Mayadev J; Covele B; Brown D; Scanderbeg D; Simon A; Frisbie-Firsching H; Yashar CM; Einck JP; Mell LK; Moore KL; Meyers SM
Brachytherapy; 2021; 20(6):1323-1333. PubMed ID: 34607771
[TBL] [Abstract][Full Text] [Related]
16. Intracavitary/Interstitial Applicator Plus Distal Parametrial Free Needle Interstitial Brachytherapy in Locally Advanced Cervical Cancer: A Dosimetric Study.
Qu HD; Han DM; Zhang N; Mao Z; Cheng GH
Front Oncol; 2020; 10():621347. PubMed ID: 33680943
[TBL] [Abstract][Full Text] [Related]
17. MRI-guided treatment-planning optimisation in intracavitary or combined intracavitary/interstitial PDR brachytherapy using tandem ovoid applicators in locally advanced cervical cancer.
Jürgenliemk-Schulz IM; Tersteeg RJ; Roesink JM; Bijmolt S; Nomden CN; Moerland MA; de Leeuw AA
Radiother Oncol; 2009 Nov; 93(2):322-30. PubMed ID: 19748695
[TBL] [Abstract][Full Text] [Related]
18. Direction Modulated Brachytherapy for Treatment of Cervical Cancer. II: Comparative Planning Study With Intracavitary and Intracavitary-Interstitial Techniques.
Han DY; Safigholi H; Soliman A; Ravi A; Leung E; Scanderbeg DJ; Liu Z; Owrangi A; Song WY
Int J Radiat Oncol Biol Phys; 2016 Oct; 96(2):440-448. PubMed ID: 27598809
[TBL] [Abstract][Full Text] [Related]
19. Multicentre treatment planning study of MRI-guided brachytherapy for cervical cancer: comparison between tandem-ovoid applicator users.
Nomden CN; de Leeuw AA; Van Limbergen E; de Brabandere M; Nulens A; Nout RA; Laman M; Ketelaars M; Lutgens L; Reniers B; Jürgenliemk-Schulz IM
Radiother Oncol; 2013 Apr; 107(1):82-7. PubMed ID: 23127774
[TBL] [Abstract][Full Text] [Related]
20. A novel minimally invasive dynamic-shield, intensity-modulated brachytherapy system for the treatment of cervical cancer.
Morcos M; Antaki M; Viswanathan AN; Enger SA
Med Phys; 2021 Jan; 48(1):71-79. PubMed ID: 32916763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
